A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells. . . . → Read More: Patent Board Rules for Broad Inst. in Crispr Case
|
|||||
       
 |
 One comment - (Comments are closed)  Intellectual property  biomedical, biotechnology, chemistry, Europe, genomics, life sciences, patent, physical sciences, university, USPTO 
A company analyzing public health data by geography and social factors received a patent for its system identifying likely opioid addiction hot spots. . . . → Read More: Patent Awarded for Opioid Risk System with Geographic Data Comments are closed Intellectual property, New products biomedical, blockchain, computer science, economics, engineering, entrepreneurs, health care, mathematics, patent, physical sciences, software, USPTO 
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery Comments are closed Intellectual property, New products biomedical, cancer, chemistry, life sciences, manufacturing, nanotechnology, patent, pharmaceuticals, USPTO 
A company creating tags similar to bar codes from nucleic acids like DNA received a patent for a process to identify and track synthetic fibers made from wood. . . . → Read More: Patent Awarded for DNA Tags on Synthetic Fibers Comments are closed Intellectual property biotechnology, chemistry, engineering, life sciences, manufacturing, materials science, patent, physical sciences, USPTO 
Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association, this weekend’s infographic on Science & Enterprise. . . . → Read More: Infographic – IBM Leads Again in Patent Awards 
An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent. . . . → Read More: Patent Awarded for Engineered T-Cell Cancer Therapy One comment - (Comments are closed) Intellectual property biomedical, biotechnology, cancer, licensing, life sciences, patent, pharmaceuticals, USPTO 
University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent One comment - (Comments are closed) Intellectual property biomedical, biotechnology, entrepreneurs, Europe, genomics, licensing, life sciences, patent, USPTO 
Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules 2 comments - (Comments are closed) Intellectual property, New products biomedical, engineering, entrepreneurs, HIV, licensing, life sciences, materials science, patent, pharmaceuticals, physical sciences, university, USPTO 
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders. . . . → Read More: Company Formed to Advance Sickle Cell Gene Therapy 2 comments - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, entrepreneurs, Europe, genomics, life sciences, patent, pharmaceuticals, stem cells, USPTO
A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies Comments are closed Intellectual property biomedical, clinical trials, engineering, heart disease, life sciences, medical device, patent, pharmaceuticals, stem cells, USPTO |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
